142 related articles for article (PubMed ID: 15644469)
1. Ertapenem-associated seizures in a peritoneal dialysis patient.
Seto AH; Song JC; Guest SS
Ann Pharmacother; 2005 Feb; 39(2):352-6. PubMed ID: 15644469
[TBL] [Abstract][Full Text] [Related]
2. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
Lunde JL; Nelson RE; Storandt HF
Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
[TBL] [Abstract][Full Text] [Related]
3. Ertapenem-associated seizures in a patient without prior CNS disorder or severe renal dysfunction.
Soštaric N; Beovic B; Maticic M
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):255-8. PubMed ID: 24472405
[TBL] [Abstract][Full Text] [Related]
4. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure.
Christie MJ; Wong K; Ting RH; Tam PY; Sikaneta TG
Ann Pharmacother; 2005 May; 39(5):953-5. PubMed ID: 15827068
[TBL] [Abstract][Full Text] [Related]
5. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.
Miller AD; Ball AM; Bookstaver PB; Dornblaser EK; Bennett CL
Pharmacotherapy; 2011 Apr; 31(4):408-23. PubMed ID: 21449629
[TBL] [Abstract][Full Text] [Related]
6. Probable codeine phosphate-induced seizures.
Kuo SC; Lin YC; Kao SM; Yang YH
Ann Pharmacother; 2004 Nov; 38(11):1848-51. PubMed ID: 15466903
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, randomized controlled pilot study of bilateral cerebellar stimulation for treatment of intractable motor seizures.
Velasco F; Carrillo-Ruiz JD; Brito F; Velasco M; Velasco AL; Marquez I; Davis R
Epilepsia; 2005 Jul; 46(7):1071-81. PubMed ID: 16026559
[TBL] [Abstract][Full Text] [Related]
8. Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency.
Fica AE; Abusada NJ
Scand J Infect Dis; 2008; 40(11-12):983-5. PubMed ID: 18759157
[TBL] [Abstract][Full Text] [Related]
9. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.
Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T
J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
Berg ML; Crank CW; Philbrick AH; Hayden MK
Ann Pharmacother; 2008 Feb; 42(2):207-12. PubMed ID: 18230703
[TBL] [Abstract][Full Text] [Related]
11. Controlled-release oxycodone-induced seizures.
Klein M; Rudich Z; Gurevich B; Lifshitz M; Brill S; Lottan M; Weksler N
Clin Ther; 2005 Nov; 27(11):1815-8. PubMed ID: 16368452
[TBL] [Abstract][Full Text] [Related]
12. Seizures associated with high cerebrospinal fluid concentrations of cefazolin.
Bechtel TP; Slaughter RL; Moore TD
Am J Hosp Pharm; 1980 Feb; 37(2):271-3. PubMed ID: 7361804
[TBL] [Abstract][Full Text] [Related]
13. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
Gu J; Huang Y
Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
Bassetti M; Righi E; Fasce R; Molinari MP; Rosso R; Di Biagio A; Mussap M; Pallavicini FB; Viscoli C
J Antimicrob Chemother; 2007 Aug; 60(2):433-5. PubMed ID: 17540673
[TBL] [Abstract][Full Text] [Related]
15. Acute prolonged neurotoxicity associated with recommended doses of ertapenem in 2 patients with advanced renal failure.
Wen MJ; Sung CC; Chau T; Lin SH
Clin Nephrol; 2013 Dec; 80(6):474-8. PubMed ID: 22579271
[TBL] [Abstract][Full Text] [Related]
16. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
[TBL] [Abstract][Full Text] [Related]
17. Acute seizures due to a probable interaction between valproic acid and meropenem.
Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
[TBL] [Abstract][Full Text] [Related]
18. Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report.
Shahar S; Arimuthu DA; Mazlan SA
BMC Nephrol; 2022 Nov; 23(1):360. PubMed ID: 36348388
[TBL] [Abstract][Full Text] [Related]
19. Ertapenem peritoneal fluid concentrations in adult surgical patients.
Arrigucci S; Garcea A; Fallani S; Cassetta MI; Canonico G; Tonelli F; Mazzei T; Novelli A
Int J Antimicrob Agents; 2009 Apr; 33(4):371-3. PubMed ID: 19097758
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
